Review



bv2 cells  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Elabscience Biotechnology bv2 cells
    (A) MARK2 siRNA reduced MARK2 expression in <t>BV2</t> cells. Western blot of BV2 cells treated with control siRNA or MARK2 siRNA. Actin was used as a loading control. Representative blots and quantitation are shown. N=3, mean ± _SD, *, p < 0.05 (Student’s t-test) (B) mRNA expression of IL-6, IFNβ, IL-1β, TNFα, IL-10, IFNα was analyzed via qRT-PCR. BV2 cells were transfected with control siRNA or MARK2 siRNA and treated with LPS (1ng/ml) for 6 hours. N=3, Mean ± SD, N.S., p>0.05, *, p<0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test)
    Bv2 Cells, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 22 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bv2+cells+complete+medium/bio_rxiv__2025__07__21__665902-41-0-2?v=Elabscience+Biotechnology
    Average 93 stars, based on 22 article reviews
    bv2 cells - by Bioz Stars, 2026-07
    93/100 stars

    Images

    1) Product Images from "MARK2 in glial cells suppresses inflammatory responses and mitigates tau toxicity"

    Article Title: MARK2 in glial cells suppresses inflammatory responses and mitigates tau toxicity

    Journal: bioRxiv

    doi: 10.1101/2025.07.21.665902

    (A) MARK2 siRNA reduced MARK2 expression in BV2 cells. Western blot of BV2 cells treated with control siRNA or MARK2 siRNA. Actin was used as a loading control. Representative blots and quantitation are shown. N=3, mean ± _SD, *, p < 0.05 (Student’s t-test) (B) mRNA expression of IL-6, IFNβ, IL-1β, TNFα, IL-10, IFNα was analyzed via qRT-PCR. BV2 cells were transfected with control siRNA or MARK2 siRNA and treated with LPS (1ng/ml) for 6 hours. N=3, Mean ± SD, N.S., p>0.05, *, p<0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test)
    Figure Legend Snippet: (A) MARK2 siRNA reduced MARK2 expression in BV2 cells. Western blot of BV2 cells treated with control siRNA or MARK2 siRNA. Actin was used as a loading control. Representative blots and quantitation are shown. N=3, mean ± _SD, *, p < 0.05 (Student’s t-test) (B) mRNA expression of IL-6, IFNβ, IL-1β, TNFα, IL-10, IFNα was analyzed via qRT-PCR. BV2 cells were transfected with control siRNA or MARK2 siRNA and treated with LPS (1ng/ml) for 6 hours. N=3, Mean ± SD, N.S., p>0.05, *, p<0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test)

    Techniques Used: Expressing, Western Blot, Control, Quantitation Assay, Quantitative RT-PCR, Transfection

    (A-C) MARK2 knockdown enhances TLR-induced cytokine expression. BV2 cells were transfected with control or MARK2 siRNA and treated with Imiquimod (1μg/ml), 3p-hpRNA (100ng/ml), or DMXAA (10μg/ml) for 6 hours. Cells were subjected to qRT-PCR to analyze mRNA levels of IL-6 and IFNβ. N=3, Mean ± SD, N.S., p>0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test).
    Figure Legend Snippet: (A-C) MARK2 knockdown enhances TLR-induced cytokine expression. BV2 cells were transfected with control or MARK2 siRNA and treated with Imiquimod (1μg/ml), 3p-hpRNA (100ng/ml), or DMXAA (10μg/ml) for 6 hours. Cells were subjected to qRT-PCR to analyze mRNA levels of IL-6 and IFNβ. N=3, Mean ± SD, N.S., p>0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test).

    Techniques Used: Knockdown, Expressing, Transfection, Control, Quantitative RT-PCR



    Similar Products

    bv2 cells  (Elabscience Biotechnology)
    93
    Elabscience Biotechnology bv2 cells
    (A) MARK2 siRNA reduced MARK2 expression in <t>BV2</t> cells. Western blot of BV2 cells treated with control siRNA or MARK2 siRNA. Actin was used as a loading control. Representative blots and quantitation are shown. N=3, mean ± _SD, *, p < 0.05 (Student’s t-test) (B) mRNA expression of IL-6, IFNβ, IL-1β, TNFα, IL-10, IFNα was analyzed via qRT-PCR. BV2 cells were transfected with control siRNA or MARK2 siRNA and treated with LPS (1ng/ml) for 6 hours. N=3, Mean ± SD, N.S., p>0.05, *, p<0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test)
    Bv2 Cells, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bv2+cells+complete+medium/bio_rxiv__2025__07__21__665902-41-0-2?v=Elabscience+Biotechnology
    Average 93 stars, based on 1 article reviews
    bv2 cells - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    bv2 cell line  (Elabscience Biotechnology)
    93
    Elabscience Biotechnology bv2 cell line
    (A) MARK2 siRNA reduced MARK2 expression in <t>BV2</t> cells. Western blot of BV2 cells treated with control siRNA or MARK2 siRNA. Actin was used as a loading control. Representative blots and quantitation are shown. N=3, mean ± _SD, *, p < 0.05 (Student’s t-test) (B) mRNA expression of IL-6, IFNβ, IL-1β, TNFα, IL-10, IFNα was analyzed via qRT-PCR. BV2 cells were transfected with control siRNA or MARK2 siRNA and treated with LPS (1ng/ml) for 6 hours. N=3, Mean ± SD, N.S., p>0.05, *, p<0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test)
    Bv2 Cell Line, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bv2+cells+complete+medium/pm39963030-59-1-7?v=Elabscience+Biotechnology
    Average 93 stars, based on 1 article reviews
    bv2 cell line - by Bioz Stars, 2026-07
    93/100 stars
    		  Buy from Supplier
    bv2 cell complete medium  (Procell Inc)
    90
    Procell Inc bv2 cell complete medium
    (A) MARK2 siRNA reduced MARK2 expression in <t>BV2</t> cells. Western blot of BV2 cells treated with control siRNA or MARK2 siRNA. Actin was used as a loading control. Representative blots and quantitation are shown. N=3, mean ± _SD, *, p < 0.05 (Student’s t-test) (B) mRNA expression of IL-6, IFNβ, IL-1β, TNFα, IL-10, IFNα was analyzed via qRT-PCR. BV2 cells were transfected with control siRNA or MARK2 siRNA and treated with LPS (1ng/ml) for 6 hours. N=3, Mean ± SD, N.S., p>0.05, *, p<0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test)
    Bv2 Cell Complete Medium, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bv2+cells+complete+medium/pm38305948-91-0-10?v=Procell+Inc
    Average 90 stars, based on 1 article reviews
    bv2 cell complete medium - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) MARK2 siRNA reduced MARK2 expression in BV2 cells. Western blot of BV2 cells treated with control siRNA or MARK2 siRNA. Actin was used as a loading control. Representative blots and quantitation are shown. N=3, mean ± _SD, *, p < 0.05 (Student’s t-test) (B) mRNA expression of IL-6, IFNβ, IL-1β, TNFα, IL-10, IFNα was analyzed via qRT-PCR. BV2 cells were transfected with control siRNA or MARK2 siRNA and treated with LPS (1ng/ml) for 6 hours. N=3, Mean ± SD, N.S., p>0.05, *, p<0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test)

    Journal: bioRxiv

    Article Title: MARK2 in glial cells suppresses inflammatory responses and mitigates tau toxicity

    doi: 10.1101/2025.07.21.665902

    Figure Lengend Snippet: (A) MARK2 siRNA reduced MARK2 expression in BV2 cells. Western blot of BV2 cells treated with control siRNA or MARK2 siRNA. Actin was used as a loading control. Representative blots and quantitation are shown. N=3, mean ± _SD, *, p < 0.05 (Student’s t-test) (B) mRNA expression of IL-6, IFNβ, IL-1β, TNFα, IL-10, IFNα was analyzed via qRT-PCR. BV2 cells were transfected with control siRNA or MARK2 siRNA and treated with LPS (1ng/ml) for 6 hours. N=3, Mean ± SD, N.S., p>0.05, *, p<0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test)

    Article Snippet: BV2 cells (Elabscience (Houston, TX)) were cultured in MEM (11095-080, Thermo Fisher Scientific) medium at 5% CO 2 and 37°C.

    Techniques: Expressing, Western Blot, Control, Quantitation Assay, Quantitative RT-PCR, Transfection

    (A-C) MARK2 knockdown enhances TLR-induced cytokine expression. BV2 cells were transfected with control or MARK2 siRNA and treated with Imiquimod (1μg/ml), 3p-hpRNA (100ng/ml), or DMXAA (10μg/ml) for 6 hours. Cells were subjected to qRT-PCR to analyze mRNA levels of IL-6 and IFNβ. N=3, Mean ± SD, N.S., p>0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test).

    Journal: bioRxiv

    Article Title: MARK2 in glial cells suppresses inflammatory responses and mitigates tau toxicity

    doi: 10.1101/2025.07.21.665902

    Figure Lengend Snippet: (A-C) MARK2 knockdown enhances TLR-induced cytokine expression. BV2 cells were transfected with control or MARK2 siRNA and treated with Imiquimod (1μg/ml), 3p-hpRNA (100ng/ml), or DMXAA (10μg/ml) for 6 hours. Cells were subjected to qRT-PCR to analyze mRNA levels of IL-6 and IFNβ. N=3, Mean ± SD, N.S., p>0.05, **, p<0.01, ***, p < 0.001 (One-way ANOVA followed by Tukey HSD test).

    Article Snippet: BV2 cells (Elabscience (Houston, TX)) were cultured in MEM (11095-080, Thermo Fisher Scientific) medium at 5% CO 2 and 37°C.

    Techniques: Knockdown, Expressing, Transfection, Control, Quantitative RT-PCR